Perspective Therapeutics (CATX) Acquisitions (2023)

Perspective Therapeutics (CATX) reported Acquisitions of $2.7 million for Q1 2023.

Perspective Therapeutics (CATX) Acquisitions (2023) Analysis & Trends

Perspective Therapeutics (CATX) has 1 years of Acquisitions data on file, last reported at $2.7 million in Q1 2023.

For the quarter ending Q1 2023, Acquisitions changed N/A year-over-year to $2.7 million; the trailing twelve-month figure through Dec 2023 stood at $2.7 million (changed N/A YoY), and the FY2023 full-year result was $2.7 million, changed N/A from the prior year.
Acquisitions steadied at $2.7 million in Q1 2023.
In the past five years, Acquisitions ranged from a high of $2.7 million in Q1 2023 to a low of $2.7 million in Q1 2023.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Abbott Laboratories	183.17 Bn	175.87 Bn	6.27 Bn	-
2	Stryker	129.06 Bn	126.18 Bn	3.81 Bn	22.00 Mn
3	Medtronic	108.35 Bn	99.13 Bn	6.41 Bn	406.00 Mn
4	Boston Scientific	68.56 Bn	67.10 Bn	3.61 Bn	523.00 Mn
5	Edwards Lifesciences	48.33 Bn	44.66 Bn	1.29 Bn	-
6	Dexcom	28.38 Bn	27.26 Bn	750.30 Mn	-
7	GE HealthCare Technologies	28.08 Bn	25.80 Bn	1.98 Bn	2.30 Bn
8	Smith & Nephew	26.93 Bn	26.36 Bn	-	-
9	Koninklijke Philips	24.06 Bn	20.93 Bn	2.07 Bn	-268.10 Mn
10	Perspective Therapeutics	300.97 Mn	300.97 Mn	-	-

Historic Data

Download Data

Date	Value
Mar 31, 2023	2.70 Mn